Selected research
Industry Growth & Trends
Global Post-translational Modifications (PTMs) Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Post-translational Modifications (PTMs) Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Post-translational Modifications (PTMs) Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Post-translational Modifications (PTMs) Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Post-translational Modifications (PTMs) Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Post-translational Modifications (PTMs) Service market include BGI Genomics, OmicScouts (Momentum Biotechnologies), Biodesix, Shanghai OE Biotech, Crown Bioscience, Shanghai Bioprofile, Creative Proteomics, Inotiv and MtoZ-Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Post-translational Modifications (PTMs) Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Post-translational Modifications (PTMs) Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Post-translational Modifications (PTMs) Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Post-translational Modifications (PTMs) Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Post-translational Modifications (PTMs) Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Post-translational Modifications (PTMs) Service Market by Company
BGI Genomics
OmicScouts (Momentum Biotechnologies)
Biodesix
Shanghai OE Biotech
Crown Bioscience
Shanghai Bioprofile
Creative Proteomics
Inotiv
MtoZ-Biolabs
CellCarta
Biognosys
MS Bioworks
Charles River Laboratories
Metware Biotechnology
Novogene
Evotec
RxCelerate
Shanghai Majorbio Bio-Pharm
Lc-Bio Technologies
CD Genomics
Discovery Life Sciences
Applied Biomics
VProteomics
Allumiqs
Westlake Omics
CDI Labs
Proteome Sciences
Sapient Bioanalytics
Proteomics International
Cosmos Wisdom
MRM Proteomics
Sinotech Genomics
Precision Biomarker Laboratories (PBL)
PTM BIO
Cell Signaling Technology (CST)
APTBIO
Post-translational Modifications (PTMs) Service Segment by Type
Phosphorylation
Acetylation
Ubiquitination
Methylation
Glycosylation
Lactylation
Redox
Palmitoylation
Others
Post-translational Modifications (PTMs) Service Segment by Application
Clinical Diagnostics
Drug Discovery
Others
Post-translational Modifications (PTMs) Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Post-translational Modifications (PTMs) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Post-translational Modifications (PTMs) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Post-translational Modifications (PTMs) Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Post-translational Modifications (PTMs) Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Phosphorylation
- Acetylation
- Ubiquitination
- Methylation
- Glycosylation
- Lactylation
- Redox
- Palmitoylation
- Others
Applications
- Clinical Diagnostics
- Drug Discovery
- Others
Companies covered
- BGI Genomics
- OmicScouts (Momentum Biotechnologies)
- Biodesix
- Shanghai OE Biotech
- Crown Bioscience
- Shanghai Bioprofile
- Creative Proteomics
- Inotiv
- MtoZ-Biolabs
- CellCarta
- Biognosys
- MS Bioworks
- Charles River Laboratories
- Metware Biotechnology
- Novogene
- Evotec
- RxCelerate
- Shanghai Majorbio Bio-Pharm
- Lc-Bio Technologies
- CD Genomics
- Discovery Life Sciences
- Applied Biomics
- VProteomics
- Allumiqs
- Westlake Omics
- CDI Labs
- Proteome Sciences
- Sapient Bioanalytics
- Proteomics International
- Cosmos Wisdom
- MRM Proteomics
- Sinotech Genomics
- Precision Biomarker Laboratories (PBL)
- PTM BIO
- Cell Signaling Technology (CST)
- APTBIO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Post-translational Modifications (PTMs) Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Post-translational Modifications (PTMs) Service Market Size by Region (2021-2032)
- 1.4.1 Global Post-translational Modifications (PTMs) Service Market Size by Region (2021-2026)
- 1.4.2 Global Post-translational Modifications (PTMs) Service Market Size by Region (2027-2032)
- 1.5 Key Regions Post-translational Modifications (PTMs) Service Market Size (2021-2032)
- 1.5.1 North America Post-translational Modifications (PTMs) Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Post-translational Modifications (PTMs) Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Post-translational Modifications (PTMs) Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Post-translational Modifications (PTMs) Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Post-translational Modifications (PTMs) Service Market Size Growth Rate (2021-2032)
2 Post-translational Modifications (PTMs) Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Phosphorylation
- 2.1.2 Acetylation
- 2.1.3 Ubiquitination
- 2.1.4 Methylation
- 2.1.5 Glycosylation
- 2.1.6 Lactylation
- 2.1.7 Redox
- 2.1.8 Palmitoylation
- 2.1.9 Others
- 2.2 Global Post-translational Modifications (PTMs) Service Market Size by Type
- 2.2.1 Global Post-translational Modifications (PTMs) Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Post-translational Modifications (PTMs) Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Post-translational Modifications (PTMs) Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Post-translational Modifications (PTMs) Service Market Size by Regions
- 2.3.1 North America Post-translational Modifications (PTMs) Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Post-translational Modifications (PTMs) Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Post-translational Modifications (PTMs) Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Post-translational Modifications (PTMs) Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Post-translational Modifications (PTMs) Service Market Size Breakdown by Type (2021-2026)
3 Post-translational Modifications (PTMs) Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinical Diagnostics
- 3.1.2 Drug Discovery
- 3.1.3 Others
- 3.2 Global Post-translational Modifications (PTMs) Service Market Size by Application
- 3.2.1 Global Post-translational Modifications (PTMs) Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Post-translational Modifications (PTMs) Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Post-translational Modifications (PTMs) Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Post-translational Modifications (PTMs) Service Market Size by Regions
- 3.3.1 North America Post-translational Modifications (PTMs) Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Post-translational Modifications (PTMs) Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Post-translational Modifications (PTMs) Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Post-translational Modifications (PTMs) Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Post-translational Modifications (PTMs) Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Post-translational Modifications (PTMs) Service Industry Trends
- 4.2 Post-translational Modifications (PTMs) Service Industry Drivers
- 4.3 Post-translational Modifications (PTMs) Service Industry Opportunities and Challenges
- 4.4 Post-translational Modifications (PTMs) Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Post-translational Modifications (PTMs) Service Revenue (2021-2026)
- 5.2 Global Post-translational Modifications (PTMs) Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Post-translational Modifications (PTMs) Service Key Company Headquarters & Area Served
- 5.4 Global Post-translational Modifications (PTMs) Service Company, Product Type & Application
- 5.5 Global Post-translational Modifications (PTMs) Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Post-translational Modifications (PTMs) Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Post-translational Modifications (PTMs) Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Post-translational Modifications (PTMs) Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 BGI Genomics
- 6.1.1 BGI Genomics Company Information
- 6.1.2 BGI Genomics Business Overview
- 6.1.3 BGI Genomics Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 BGI Genomics Post-translational Modifications (PTMs) Service Product Portfolio
- 6.1.5 BGI Genomics Recent Developments
- 6.2 OmicScouts (Momentum Biotechnologies)
- 6.2.1 OmicScouts (Momentum Biotechnologies) Company Information
- 6.2.2 OmicScouts (Momentum Biotechnologies) Business Overview
- 6.2.3 OmicScouts (Momentum Biotechnologies) Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 OmicScouts (Momentum Biotechnologies) Post-translational Modifications (PTMs) Service Product Portfolio
- 6.2.5 OmicScouts (Momentum Biotechnologies) Recent Developments
- 6.3 Biodesix
- 6.3.1 Biodesix Company Information
- 6.3.2 Biodesix Business Overview
- 6.3.3 Biodesix Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Biodesix Post-translational Modifications (PTMs) Service Product Portfolio
- 6.3.5 Biodesix Recent Developments
- 6.4 Shanghai OE Biotech
- 6.4.1 Shanghai OE Biotech Company Information
- 6.4.2 Shanghai OE Biotech Business Overview
- 6.4.3 Shanghai OE Biotech Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Shanghai OE Biotech Post-translational Modifications (PTMs) Service Product Portfolio
- 6.4.5 Shanghai OE Biotech Recent Developments
- 6.5 Crown Bioscience
- 6.5.1 Crown Bioscience Company Information
- 6.5.2 Crown Bioscience Business Overview
- 6.5.3 Crown Bioscience Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Crown Bioscience Post-translational Modifications (PTMs) Service Product Portfolio
- 6.5.5 Crown Bioscience Recent Developments
- 6.6 Shanghai Bioprofile
- 6.6.1 Shanghai Bioprofile Company Information
- 6.6.2 Shanghai Bioprofile Business Overview
- 6.6.3 Shanghai Bioprofile Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Shanghai Bioprofile Post-translational Modifications (PTMs) Service Product Portfolio
- 6.6.5 Shanghai Bioprofile Recent Developments
- 6.7 Creative Proteomics
- 6.7.1 Creative Proteomics Company Information
- 6.7.2 Creative Proteomics Business Overview
- 6.7.3 Creative Proteomics Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Creative Proteomics Post-translational Modifications (PTMs) Service Product Portfolio
- 6.7.5 Creative Proteomics Recent Developments
- 6.8 Inotiv
- 6.8.1 Inotiv Company Information
- 6.8.2 Inotiv Business Overview
- 6.8.3 Inotiv Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Inotiv Post-translational Modifications (PTMs) Service Product Portfolio
- 6.8.5 Inotiv Recent Developments
- 6.9 MtoZ-Biolabs
- 6.9.1 MtoZ-Biolabs Company Information
- 6.9.2 MtoZ-Biolabs Business Overview
- 6.9.3 MtoZ-Biolabs Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 MtoZ-Biolabs Post-translational Modifications (PTMs) Service Product Portfolio
- 6.9.5 MtoZ-Biolabs Recent Developments
- 6.10 CellCarta
- 6.10.1 CellCarta Company Information
- 6.10.2 CellCarta Business Overview
- 6.10.3 CellCarta Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 CellCarta Post-translational Modifications (PTMs) Service Product Portfolio
- 6.10.5 CellCarta Recent Developments
- 6.11 Biognosys
- 6.11.1 Biognosys Company Information
- 6.11.2 Biognosys Business Overview
- 6.11.3 Biognosys Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Biognosys Post-translational Modifications (PTMs) Service Product Portfolio
- 6.11.5 Biognosys Recent Developments
- 6.12 MS Bioworks
- 6.12.1 MS Bioworks Company Information
- 6.12.2 MS Bioworks Business Overview
- 6.12.3 MS Bioworks Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 MS Bioworks Post-translational Modifications (PTMs) Service Product Portfolio
- 6.12.5 MS Bioworks Recent Developments
- 6.13 Charles River Laboratories
- 6.13.1 Charles River Laboratories Company Information
- 6.13.2 Charles River Laboratories Business Overview
- 6.13.3 Charles River Laboratories Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Charles River Laboratories Post-translational Modifications (PTMs) Service Product Portfolio
- 6.13.5 Charles River Laboratories Recent Developments
- 6.14 Metware Biotechnology
- 6.14.1 Metware Biotechnology Company Information
- 6.14.2 Metware Biotechnology Business Overview
- 6.14.3 Metware Biotechnology Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Metware Biotechnology Post-translational Modifications (PTMs) Service Product Portfolio
- 6.14.5 Metware Biotechnology Recent Developments
- 6.15 Novogene
- 6.15.1 Novogene Company Information
- 6.15.2 Novogene Business Overview
- 6.15.3 Novogene Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Novogene Post-translational Modifications (PTMs) Service Product Portfolio
- 6.15.5 Novogene Recent Developments
- 6.16 Evotec
- 6.16.1 Evotec Company Information
- 6.16.2 Evotec Business Overview
- 6.16.3 Evotec Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Evotec Post-translational Modifications (PTMs) Service Product Portfolio
- 6.16.5 Evotec Recent Developments
- 6.17 RxCelerate
- 6.17.1 RxCelerate Company Information
- 6.17.2 RxCelerate Business Overview
- 6.17.3 RxCelerate Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 RxCelerate Post-translational Modifications (PTMs) Service Product Portfolio
- 6.17.5 RxCelerate Recent Developments
- 6.18 Shanghai Majorbio Bio-Pharm
- 6.18.1 Shanghai Majorbio Bio-Pharm Company Information
- 6.18.2 Shanghai Majorbio Bio-Pharm Business Overview
- 6.18.3 Shanghai Majorbio Bio-Pharm Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Shanghai Majorbio Bio-Pharm Post-translational Modifications (PTMs) Service Product Portfolio
- 6.18.5 Shanghai Majorbio Bio-Pharm Recent Developments
- 6.19 Lc-Bio Technologies
- 6.19.1 Lc-Bio Technologies Company Information
- 6.19.2 Lc-Bio Technologies Business Overview
- 6.19.3 Lc-Bio Technologies Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Lc-Bio Technologies Post-translational Modifications (PTMs) Service Product Portfolio
- 6.19.5 Lc-Bio Technologies Recent Developments
- 6.20 CD Genomics
- 6.20.1 CD Genomics Company Information
- 6.20.2 CD Genomics Business Overview
- 6.20.3 CD Genomics Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 CD Genomics Post-translational Modifications (PTMs) Service Product Portfolio
- 6.20.5 CD Genomics Recent Developments
- 6.21 Discovery Life Sciences
- 6.21.1 Discovery Life Sciences Company Information
- 6.21.2 Discovery Life Sciences Business Overview
- 6.21.3 Discovery Life Sciences Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Discovery Life Sciences Post-translational Modifications (PTMs) Service Product Portfolio
- 6.21.5 Discovery Life Sciences Recent Developments
- 6.22 Applied Biomics
- 6.22.1 Applied Biomics Company Information
- 6.22.2 Applied Biomics Business Overview
- 6.22.3 Applied Biomics Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Applied Biomics Post-translational Modifications (PTMs) Service Product Portfolio
- 6.22.5 Applied Biomics Recent Developments
- 6.23 VProteomics
- 6.23.1 VProteomics Company Information
- 6.23.2 VProteomics Business Overview
- 6.23.3 VProteomics Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 VProteomics Post-translational Modifications (PTMs) Service Product Portfolio
- 6.23.5 VProteomics Recent Developments
- 6.24 Allumiqs
- 6.24.1 Allumiqs Company Information
- 6.24.2 Allumiqs Business Overview
- 6.24.3 Allumiqs Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.24.4 Allumiqs Post-translational Modifications (PTMs) Service Product Portfolio
- 6.24.5 Allumiqs Recent Developments
- 6.25 Westlake Omics
- 6.25.1 Westlake Omics Company Information
- 6.25.2 Westlake Omics Business Overview
- 6.25.3 Westlake Omics Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.25.4 Westlake Omics Post-translational Modifications (PTMs) Service Product Portfolio
- 6.25.5 Westlake Omics Recent Developments
- 6.26 CDI Labs
- 6.26.1 CDI Labs Company Information
- 6.26.2 CDI Labs Business Overview
- 6.26.3 CDI Labs Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.26.4 CDI Labs Post-translational Modifications (PTMs) Service Product Portfolio
- 6.26.5 CDI Labs Recent Developments
- 6.27 Proteome Sciences
- 6.27.1 Proteome Sciences Company Information
- 6.27.2 Proteome Sciences Business Overview
- 6.27.3 Proteome Sciences Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.27.4 Proteome Sciences Post-translational Modifications (PTMs) Service Product Portfolio
- 6.27.5 Proteome Sciences Recent Developments
- 6.28 Sapient Bioanalytics
- 6.28.1 Sapient Bioanalytics Company Information
- 6.28.2 Sapient Bioanalytics Business Overview
- 6.28.3 Sapient Bioanalytics Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.28.4 Sapient Bioanalytics Post-translational Modifications (PTMs) Service Product Portfolio
- 6.28.5 Sapient Bioanalytics Recent Developments
- 6.29 Proteomics International
- 6.29.1 Proteomics International Company Information
- 6.29.2 Proteomics International Business Overview
- 6.29.3 Proteomics International Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.29.4 Proteomics International Post-translational Modifications (PTMs) Service Product Portfolio
- 6.29.5 Proteomics International Recent Developments
- 6.30 Cosmos Wisdom
- 6.30.1 Cosmos Wisdom Company Information
- 6.30.2 Cosmos Wisdom Business Overview
- 6.30.3 Cosmos Wisdom Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.30.4 Cosmos Wisdom Post-translational Modifications (PTMs) Service Product Portfolio
- 6.30.5 Cosmos Wisdom Recent Developments
- 6.31 MRM Proteomics
- 6.31.1 MRM Proteomics Company Information
- 6.31.2 MRM Proteomics Business Overview
- 6.31.3 MRM Proteomics Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.31.4 MRM Proteomics Post-translational Modifications (PTMs) Service Product Portfolio
- 6.31.5 MRM Proteomics Recent Developments
- 6.32 Sinotech Genomics
- 6.32.1 Sinotech Genomics Company Information
- 6.32.2 Sinotech Genomics Business Overview
- 6.32.3 Sinotech Genomics Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.32.4 Sinotech Genomics Post-translational Modifications (PTMs) Service Product Portfolio
- 6.32.5 Sinotech Genomics Recent Developments
- 6.33 Precision Biomarker Laboratories (PBL)
- 6.33.1 Precision Biomarker Laboratories (PBL) Company Information
- 6.33.2 Precision Biomarker Laboratories (PBL) Business Overview
- 6.33.3 Precision Biomarker Laboratories (PBL) Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.33.4 Precision Biomarker Laboratories (PBL) Post-translational Modifications (PTMs) Service Product Portfolio
- 6.33.5 Precision Biomarker Laboratories (PBL) Recent Developments
- 6.34 PTM BIO
- 6.34.1 PTM BIO Company Information
- 6.34.2 PTM BIO Business Overview
- 6.34.3 PTM BIO Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.34.4 PTM BIO Post-translational Modifications (PTMs) Service Product Portfolio
- 6.34.5 PTM BIO Recent Developments
- 6.35 Cell Signaling Technology (CST)
- 6.35.1 Cell Signaling Technology (CST) Company Information
- 6.35.2 Cell Signaling Technology (CST) Business Overview
- 6.35.3 Cell Signaling Technology (CST) Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.35.4 Cell Signaling Technology (CST) Post-translational Modifications (PTMs) Service Product Portfolio
- 6.35.5 Cell Signaling Technology (CST) Recent Developments
- 6.36 APTBIO
- 6.36.1 APTBIO Company Information
- 6.36.2 APTBIO Business Overview
- 6.36.3 APTBIO Post-translational Modifications (PTMs) Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.36.4 APTBIO Post-translational Modifications (PTMs) Service Product Portfolio
- 6.36.5 APTBIO Recent Developments
7 North America
- 7.1 North America Post-translational Modifications (PTMs) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Post-translational Modifications (PTMs) Service Market Size by Country (2021-2026)
- 7.3 North America Post-translational Modifications (PTMs) Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Post-translational Modifications (PTMs) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Post-translational Modifications (PTMs) Service Market Size by Country (2021-2026)
- 8.3 Europe Post-translational Modifications (PTMs) Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Post-translational Modifications (PTMs) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Post-translational Modifications (PTMs) Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Post-translational Modifications (PTMs) Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Post-translational Modifications (PTMs) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Post-translational Modifications (PTMs) Service Market Size by Country (2021-2026)
- 10.3 South America Post-translational Modifications (PTMs) Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Post-translational Modifications (PTMs) Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Post-translational Modifications (PTMs) Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Post-translational Modifications (PTMs) Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst